Blogger Jade Ed says the "same standards for good scientific practice" that research groups must adhere to when reporting results should also apply to life science suppliers that are marketing products, "especially when the results are going into Application Notes or Technical Reports that the company is trying to pass off as real papers." Before working in biotech, Jade Ed never "put much stock into" vendors' marketing materials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.